Showing results (61-70 of 89) with videos related to
Sort By:
Pageof 9
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1996
Selective N-type neuronal voltage-sensitive calcium channel blocker, SNX-111, produces spinal antinociception in rat models of acute, persistent and neuropathic painS S Bowersox, T Gadbois, T Singh, et al.American Heart Journal|April 1, 1989
The effects of terazosin and methyclothiazide on blood pressure and serum lipidsR R Luther, H N Glassman, C B Estep, et al.Circulation|June 1, 1990
Assessment of renin dependency of hypertension with a dipeptide renin inhibitorM A Weber, J M Neutel, I Essinger, et al.American Journal of Obstetrics and Gynecology|March 1, 1984
Evaluation of a rapid method for the detection of vaginal group B streptococci in women in laborE P Reardon, M A Noble, E R Luther, et al.Pneumologie (Stuttgart, Germany)|September 9, 2008
[Venous aneurysmatic malformation of the chest wall as a rare cause of pulmonary embolism--a case report]R Luther, F Meyer, J Ricke, et al.Journal of Human Hypertension|April 1, 1990
Effects of terazosin on serum lipid levels in hypertensive blacksR R Luther, M J Klepper, C J Maurath, et al.Journal of Human Hypertension|April 1, 1990
Efficacy of terazosin in the treatment of essential hypertension in blacksR R Luther, M J Klepper, C J Maurath, et al.American Journal of Hypertension|July 1, 1988
Terazosin, a new selective alpha 1-adrenergic blocking agent. Results of long-term treatment in patients with essential hypertensionR R Luther, H N Glassman, C B Estep, et al.Clinical Therapeutics|January 1, 1988
Effect of age on the pharmacokinetics of orally and intravenously administered terazosinL T Sennello, R C Sonders, H N Glassman, et al.Journal of Cardiovascular Pharmacology|January 1, 1990
Clinical pharmacology of enalkiren, a novel, dipeptide renin inhibitorH N Glassman, H D Kleinert, R S Boger, et al.Pageof 9